-+ 0.00%
-+ 0.00%
-+ 0.00%

Goldman Sachs Initiates Coverage On City Therapeutics with Early-Stage Biotech Rating

Benzinga·11/10/2026 12:00:38
Listen to the news
Goldman Sachs analyst Salveen Richter initiates coverage on City Therapeutics (NASDAQ:CTY) with a Early-Stage Biotech rating.